Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole
We have just commenced recruiting patients into a new trial which funded by an NIHR HTA Grant with Chief Investigator Professor Andrew...
top of page
Search
Glenn Hearson
- Aug 26, 2021
Study to assess remote monitoring of patients with an interstitial lung disease
We will be shortly commencing a new study to find out if it is practical for patients with a fibrotic lung disease, to take their own...
142
Glenn Hearson
- Apr 12, 2021
Understanding Patient Priorities for Scientific Research on Pulmonary Fibrosis
Dr Amanda Goodwin, Dr Amanda Tatler and Dr Rachel Clifford, along with many other researchers in Translational Medical Science at the...
206
Glenn Hearson
- Oct 5, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study
95
Glenn Hearson
- Mar 30, 2020
Nottingham Covid Research Group website launched
The Group will nvestigate the pathogenesis, treatment and complications of lung disease caused by the SARS-CoV-2 virus
494
Glenn Hearson
- Dec 13, 2019
Midlands Interstitial Lung Disease (MILD) Educational Meeting
This exciting event was organised by Natalie Stevenson, Lucy Howard and Dr Fasihul Khan from the ILD team of the University of Nottingham
138
Glenn Hearson
- Nov 11, 2019
Midlands ILD (MILD) Fibrosis Meeting 2019 Brochure Now available
The brochure for the Midlands ILD Fibrosis (MILD) Meeting, being held in the beautiful Trent Building at the University of Nottingham campus
31
Glenn Hearson
- Aug 20, 2019
Dr Jennifer Cairns:Investigating Elk-1 Mediated Molecular Mechanisms
Dr Jennifer Cairns:Investigating Elk-1 Mediated Molecular Mechanisms
341
bottom of page